Ireland
--:--IST
Priya Life Science Clinical trial register
Trackers› Clinical trials› Amagasaki-Shi
Clinical trial register · Japan

Clinical Trials in Amagasaki-Shi, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Japan and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 2516 matching records held by the registry are in this view. Synced 12 Nov 2026, 03:19 UTC
2516
Studies in scope
all four open statuses
1285
Recruiting now
open to new participants
352
Lead sponsors
across recruiting studies
Top sites
Fukuoka 557 Nagoya 513 Sapporo 400 Tokyo 375 Osaka 354

Trials with a site in Amagasaki-Shi

19 of 2516 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Japan
Start
Recruiting
4D Molecular Therapeutics
Phase 3
514
Mito, Amagasaki-shi, Fukuoka, Fukushima, Hachioji-shi, Kagoshima, Kita-Gun, Kobe
2026-09-18
Recruiting
AstraZeneca
Phase 3
800
Amagasaki-shi, Chiba, Chitose-shi, Chūōku, Koga-shi, Minatoku, Okayama, Oyama-shi
2026-07-06
Recruiting
AstraZeneca
Phase 3
4,500
Amagasaki-shi, Chūōku, Kasugai-shi, Koga-shi, Maebashi, Minatoku, Naka, Shinjuku-ku
2026-06-29
Recruiting
Takeda
Phase 3
300
Nagoya, Fukushima, Gifu, Fukuyama-shi, Amagasaki-shi, Mibu, Bunkyo-ku, Shinagawa-ku
2026-05-21
Recruiting
Regeneron Pharmaceuticals
Phase 3
2,000
Amagasaki-shi, Tomigusuku, Kawachi-Nagano, Kita-Ku, Bunkyo-ku, Saga
2025-06-25
Active, closed
Amgen
Phase 3
279
Nagoya, Fukuoka, Onga-gun, Hashima-gun, Sapporo, Amagasaki-shi, Kobe, Naka
2025-06-13
Recruiting
Boehringer Ingelheim
Phase 3
4,200
Amagasaki-shi, Asahi-shi, Fujisawa-shi, Fukuoka, Fukuoka, Chikushino, Gunma, Maebashi, Hachioji-shi, Hamada-shi
2025-05-20
Recruiting
AstraZeneca
Phase 3
11,300
Amagasaki-shi, Asahikawa-shi, Azumino-shi, Chūōku, Fukui-shi, Hakusan-shi, Himeji, Izumo-shi
2025-03-14
Recruiting
AstraZeneca
Phase 3
5,000
Aira, Amagasaki-shi, Beppu-shi, Chigasaki-shi, Fujinomiya-shi, Hakodate-shi, Hamamatsu, Higashihiroshima-shi
2025-03-03
Recruiting
AstraZeneca
Phase 3
1,160
Amagasaki-shi, Bunkyō City, Chūōku, Fukuoka, Hiroshima, Kawagoe-shi, Kawasaki-shi, Kitaadachi-gun
2024-11-27
Recruiting
AstraZeneca
Phase 3
1,160
Amagasaki-shi, Bunkyō City, Chūōku, Fukuoka, Hirakata-shi, Hiroshima, Kakogawa-shi, Kanazawa
2024-11-18
Recruiting
Boehringer Ingelheim
Phase 2
175
Akita, Amagasaki-shi, Fukuoka, Fukushima, Hachioji-shi, Kagawa, Kita-gun, Kagoshima, Kashihara
2024-05-15
Active, closed
AstraZeneca
Phase 3
863
Amagasaki-shi, Hakodate-shi, Hiroshima, Kitaadachi-gun, Kitakyushu-shi, Matsuyama, Nagoya, Nishinomiya-shi
2023-11-09
Recruiting
Protara Therapeutics
Phase 2
131
Komaki-shi, Nagoya, Funabashi-shi, Sakura-shi, Fukuoka, Amagasaki-shi, Hitachi-shi, Yokohama
2023-09-15
Active, closed
Viatris Innovation GmbH
Phase 3
470
Amagasaki-shi, Bunkyō City, Chiba, Chuo-shi, Chūōku, Fukuoka, Hiroshima, Hitachi-Naka
2022-12-13
By invitation
Viatris Innovation GmbH
Phase 3
25,000
Akishima-shi, Amagasaki-shi, Asahi-shi, Bunkyō City, Chiba, Chikushino-shi, Chūō, Daito-shi
2021-08-14
Active, closed
Sanofi
Observational
955
Nagakute-shi, Obihiro-shi, Sapporo, Hirakata-shi, Koshigaya-shi, Shimotsuga-gun, tabashi City, Amagasaki-shi
2019-06-11
Active, closed
AbbVie
Phase 3
1,533
Nagoya, Fukuoka, Hiroshima, Sapporo, Amagasaki-shi, Sagamihara-shi, Yokohama, Kyoto
2018-08-09
Rows per page Showing 1–19 of 19
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Japanese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 13 November 2026. https://priyalifescience.com/clinical-trials-japan/city/amagasaki-shi

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Japan and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 2,516 studies in total at the last sync on 12 Nov 2026, 03:19 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 19 of those studies with a site in Amagasaki-Shi.

How many clinical trials are recruiting in Amagasaki-Shi?

12 of the 19 studies on this page are recruiting new participants as of the 12 Nov 2026, 03:19 UTC sync. A further 0 have not yet opened recruitment, 6 are active but closed to new participants, and 1 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Amagasaki-Shi), 19 studies
PhaseStudiesRecruitingShare
Phase 3161084.2%
Phase 22210.5%
Observational105.3%

Most active sponsors

Lead sponsors with the most studies (Amagasaki-Shi)
Lead sponsorStudiesRecruiting
AstraZeneca76
Boehringer Ingelheim22
Viatris Innovation GmbH20
4D Molecular Therapeutics11
AbbVie10
Amgen10
Celgene10
Protara Therapeutics11
Regeneron Pharmaceuticals11
Sanofi10
→

Other trial registries in Japan

This register lists Japan studies from ClinicalTrials.gov. Many studies in Japan are registered only in a national registry. We do not copy those records; search them directly:

  • jRCT (Japan Registry of Clinical Trials) — run by the Ministry of Health, Labour and Welfare; trials under Japan's Clinical Trials Act and other clinical research
  • UMIN-CTR — run by the University of Tokyo Hospital's UMIN Center; many academic and investigator-led studies
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.